V. Castel

Type de document

Co-auteur

G. Laureys

R. Ladenstein

P.F. Ambros

A. Vicha

N. Van Roy

D. Valteau-Couanet

D.A. Tweddle

S. Taschner-Mandl

G Schleiermacher

H Rubie

M. Rossing

U. Pötschger

M. Popovic-Beck

G. Pierron

A.D. Pearson

R. Noguera

A. Muhlethaler-Mottet

V. Mosseri

M. Morini

J. Michon

K. Mazzocco

T. Martinsson

B. Marques

J. Malis

R. Luksch

E. Lapouble

P. Kogner

I. Jiménez

M. Jeison

S.L. George

A. Foot

J. Font de Mora

M. Elliott

O. Delattre

Y. de Rycke

K. de Preter

A.F. de Lacerda

J. De Kraker

B. De Bernardi

M. Conte

V. Combaret

N Clément

L. Chesler

P. Bruzzi

N. Bown

J. Bhalshankar

D.R. Betts

M. Bernkopf

V. Bernard

A. Bellini

K. Beiske

M. Beck-Popovic

S. Baulande

W. Balwierz

N. Auger

S. Ash

Date

Source

Serveur académique Lausannois (2)

Mot-clé

nourisson (2) Europe (2) maladie (2) taux (2) survie (2) Europe (2) Treatment (2) Ci (Chinese poetry) (2) Survival (2) Prognosis (2) Patients (2) Neuroblastoma (2) Human beings (2) Europe (2) Prognosis (2) Patients (2) nourrisson (2) maladie (2) risque (1) mutation (1) modèle (1) danger (1) gène (1) point (1) enfant (1) procès (1) Surgery (1) Complications (1) Children (1) Inhibitors (1)

Documents écrit par V. Castel (2) | parle de V. Castel (4)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).

A. Bellini et al. (20 oct. 2021)

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

B. De Bernardi et al. (2008)